『Medical Device Global Market Access』のカバーアート

Medical Device Global Market Access

Medical Device Global Market Access

著者: Pure Global
無料で聴く

このコンテンツについて

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to technical-file skeletons, we break down the documents you’ll need and the pitfalls reviewers love to flag. • AI-powered insights – Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won’t hear at conferences—or from competitors. What you’ll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a “reg-first” QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regions Whether you’re plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue. ⸻ Brought to you by Pure Global – the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 + countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today.Copyright 2025 Pure Global
エピソード
  • Your Blueprint for Global MedTech Compliance
    2025/09/29
    Choosing the right international standards is a critical strategic decision for any medical device manufacturer. This episode provides a clear framework for navigating the complex world of MedTech standards, starting with the foundational requirements for quality management (ISO 13485), risk management (ISO 14971), and software (IEC 62304). We explore how to build upon this core to select device-specific standards that ensure safety, efficacy, and smoother regulatory submissions worldwide, including the latest implications of the FDA's alignment with ISO 13485. Key Questions: • Which single standard forms the bedrock of a global medical device Quality Management System? • How will the FDA’s new rule, effective February 2, 2026, change quality system requirements in the US? • What is the required process for systematically identifying and controlling device risks for regulators? • If your device has software, which standard is absolutely essential for compliance? • Why is the ISO 10993 series on biocompatibility critical for ensuring patient safety? • How do you move beyond foundational standards to select ones specific to your device's technology, like sterilization or usability? • What are the strategic benefits of integrating standards compliance early in the design process? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.
    続きを読む 一部表示
    4 分
  • Is Your MedTech Firm Ready for Europe? Avoiding Critical EU MDR Pitfalls
    2025/09/28
    This episode delves into the most common and costly mistakes medical technology companies make when seeking EU MDR compliance. We break down the complexities of technical documentation, clinical evidence requirements, risk management, and post-market surveillance, offering actionable strategies to avoid these pitfalls, streamline your submission process, and prevent significant delays and rejections from Notified Bodies. Key Questions: • Is your technical documentation truly 'reviewer-ready'? • Are you underestimating the new bar for clinical evidence under the MDR? • Does your risk management file accurately reflect your device's entire lifecycle? • Is your Post-Market Surveillance (PMS) plan proactive or just reactive? • How can you avoid the most common reasons for Notified Body pushback? • What makes a Clinical Evaluation Report (CER) robust enough for the MDR? • Are inconsistencies in your documentation putting your submission at risk? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.
    続きを読む 一部表示
    4 分
  • Regulatory Foresight: A Blueprint for Global MedTech Success
    2025/09/27
    This episode provides MedTech innovators with a foundational blueprint for embedding a global regulatory strategy into their product development process from the very beginning. We explore why a reactive, market-by-market approach fails and outline the critical early-stage decisions in market selection, quality management, and clinical evidence that pave the way for faster, more efficient international market access. Key Questions: • Why is a 'launch and learn' regulatory approach so risky for new devices? • How can early market selection influence your core product design? • What is the single most important standard to build your global strategy upon? • How do you design a clinical trial to satisfy multiple global regulators simultaneously? • What are the hidden costs of ignoring labeling and translation requirements until the last minute? • How has the EU MDR changed the game for clinical evidence worldwide? • When should you really start budgeting for global regulatory submissions? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.
    続きを読む 一部表示
    4 分
まだレビューはありません